HSP90 inhibitor 17AAG causes apoptosis in ATRA-resistant acute promyelocytic leukemia cells

被引：11
作者：
Meyer, Paul N. [1 ]
Roychowdhury, Shantanu [1 ]
Kini, Ameet R. [1 ]
Alkan, Serhan [1 ]
机构：
[1] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA
来源：
LEUKEMIA RESEARCH | 2008年 / 32卷 / 01期
关键词：
acute promyelocytic leukemia; APL; 17AAG; heat shock protein; HSP90; apoptosis; therapy; geldanamycin;
D O I：
10.1016/j.leukres.2007.05.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The effects of a novel heat shock protein inhibitor, 17AAG, on established APL cell lines (NB4 and R1) were analyzed. 17AAG induces apoptosis in APL cell lines both sensitive (NB4) and resistant (R 1) to ATRA after 72 h of incubation. Apoptosis occurs by a mechanism different than ATRA-inediated response, as the cells do not undergo differentiation before apoptosis. Analysis of bax and bcl-2 shows that pro-apoptotic (bax) and anti-apoptotic (bcl-2) proteins are decreased in expression after incubation with 17AAG. We believe this data supports potential clinical use of agents that target HSP90 in APL patients failing conventional therapy. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：143 / 149
页数：7
相关论文
共 50 条
  • [21] Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma
    Duus, J.
    Bahar, H. I.
    Venkataraman, G.
    Ozpuyan, F.
    Izban, K. F.
    Al-Masri, H.
    Maududi, T.
    Toor, A.
    Alkan, S.
    LEUKEMIA & LYMPHOMA, 2006, 47 (07) : 1369 - 1378
  • [22] Spotlight on 17-AAG as an Hsp90 inhibitor for molecular targeted cancer treatment
    Talaei, Sona
    Mellatyar, Hassan
    Asadi, Asadollah
    Akbarzadeh, Abolfazl
    Sheervalilou, Roghayeh
    Zarghami, Nosratollah
    CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 93 (05) : 760 - 786
  • [23] Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia
    Agis, H
    Weltermann, A
    Mitterbauer, G
    Thalhammer, R
    Edelhäuser, M
    Seewann, HL
    Valent, P
    Lechner, K
    Fonatsch, C
    Geissler, K
    ANNALS OF HEMATOLOGY, 1999, 78 (07) : 329 - 332
  • [24] Alleviating neurodegeneration by an anticancer agent - An Hsp90 inhibitor (17-AAG)
    Waza, Masahiro
    Adachi, Hiroaki
    Katsuno, Masahisa
    Minamiyama, Makoto
    Tanaka, Fumiaki
    Sobue, Gen
    INTEGRATED MOLECULAR MEDICINE FOR NEURONAL AND NEOPLASTIC DISORDERS, 2006, 1086 : 21 - 34
  • [25] Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors
    Vaseva, A. V.
    Yallowitz, A. R.
    Marchenko, N. D.
    Xu, S.
    Moll, U. M.
    CELL DEATH & DISEASE, 2011, 2 : e156 - e156
  • [26] Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer
    Weber, Helga
    Valbuena, Jose R.
    Barbhuiya, Mustafa A.
    Stein, Stefan
    Kunkel, Hana
    Garcia, Patricia
    Bizama, Carolina
    Riquelme, Ismael
    Espinoza, Jaime A.
    Kurtz, Stephen E.
    Tyner, Jeffrey W.
    Francisco Calderon, Juan
    Corvalan, Alejandro H.
    Grez, Manuel
    Pandey, Akhilesh
    Leal-Rojas, Pamela
    Roa, Juan C.
    ONCOTARGET, 2017, 8 (16) : 26169 - 26184
  • [27] Pharmacological targeting of HSP90 with 17-AAG induces apoptosis of myogenic cells through activation of the intrinsic pathway
    Akira Wagatsuma
    Yuzo Takayama
    Takayuki Hoshino
    Masataka Shiozuka
    Shigeru Yamada
    Ryoichi Matsuda
    Kunihiko Mabuchi
    Molecular and Cellular Biochemistry, 2018, 445 : 45 - 58
  • [28] Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors
    A V Vaseva
    A R Yallowitz
    N D Marchenko
    S Xu
    U M Moll
    Cell Death & Disease, 2011, 2 : e156 - e156
  • [29] Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptor
    Komura, Naoyuki
    Ikeda, Yoko
    Masuda, Natsuko
    Umezawa, Yoji
    Ito, Keisuke
    Kizaki, Masahiro
    Umezawa, Kazuo
    LEUKEMIA RESEARCH, 2007, 31 (03) : 301 - 313
  • [30] SNX-25a, a novel Hsp90 inhibitor, inhibited human cancer growth more potently than 17-AAG
    Wang, Shaoxiang
    Wang, Xiao
    Du, Zhan
    Liu, Yuting
    Huang, Dane
    Zheng, Kai
    Liu, Kaisheng
    Zhang, Yi
    Zhong, Xueyun
    Wang, Yifei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 450 (01) : 73 - 80
12345